TGFB1 and renal fibrosis: Several studies have demonstrated that TGF-β increases cellular ROS through Smad-NOX4 signaling [28–30] and the TGF-β1/Smad signaling pathway is an important pathogenic mechanism in cardiac, hepatic, pulmonary, and renal fibrosis [41].